Dallas, TX -- (ReleaseWire) -- 07/08/2014 -- ReportsnReports.com adds Cardiac Rhythm Management (CRM) Devices Market - Global Trends, Estimates and Forecasts, 2012-2018 new report in its store.
The Cardiac Rhythm Management Devices market value is expected to reach US$20.9 billion by 2017, primarily supported by the product types - Cardiac Defibrillators, Cardiac Pacemakers Devices and Cardiac Resynchronization Therapy. Globally, Cardiac Defibrillatorsand Pacemakers Devices together account for approximately 80% of the market share to support the Cardiac Rhythm Management Devices Industry going forward.
Geographical analysis for Cardiac Defibrillators market shows that the highest Compounded Annual Growth Rate (CAGR) of 11% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Europe follows Asia-Pacific with a CAGR of 8.7% while the North America forecasts to drive with a growth rate of 8.2%.
Purchase Report Directly @ http://www.reportsnreports.com/Purchase.aspx?name=291366.
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
The report ?Cardiac Rhythm Management (CRM) Devices - Global Trends, Estimates and Forecasts, 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.
Request Sample for this Report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=291366.
The report primarily focuses on:
Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
The analysis primarily deals with by type. Further, the subdivided categories include:
Cardiac Rhythm Management (CRM) Devices - By Type
1. Cardiac Defibrillators
a. Implantable Cardioverter Defibrillators (ICD)
b. Automated External Defibrillator (AED)
I. Manual External Defibrillator
II. Semi-Automatic Defibrillator
2. Cardiac Pacemakers
a. Implantable Pacemakers
I. Single-Chamber Pacemakers
II. Dual-Chamber Pacemakers
III. Biventricular Pacemakers
b. External Pacemakers
3. Cardiac Resynchronization Therapy (CRT)
a. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
b. Cardiac Resynchronization Pacemakers (CRT-P)
The period considered for the cardiac rhythm management devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 251 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.